News
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
Science Featured on MSN6h
Popular Diabetes Drug Linked to Rare Vision Loss in New StudyResearch shows semaglutide, for diabetes and weight loss, may slightly increase vision risk, linked to a rare condition causing sudden, irreversible vision loss from optic nerve damage.
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...
A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.
But now, a new study has revealed yet another ... 481 psychiatric events were associated with not only semaglutide, but also other similar drugs liraglutide and tirzepatide, often sold as Mounjaro.
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
From ‘Ozempic face’ to ‘Ozempic fingers’ and even ‘Wegovy butt,’ the potential side effects of weight loss medications have ...
Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...
Novo Nordisk now has an Ozempic pill. Citing a Novo spokesperson, pharmaceuticals news site BioPharmaDive reported yesterday ...
Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...
Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results